Literature DB >> 18427983

Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes.

Aroldo Cupello1, Daniela Audenino, Simona Scarrone, Michele Fornaro, Elena Gatta, Pantaleo Fornaro, Claudio Albano.   

Abstract

The density of the serotonin transporter in the plasma membranes of blood platelets was evaluated by labelled paroxetine binding in three different groups. These groups were: normal controls, epileptic patients having undergone a recent seizure (less than 4 days before) and patients who equally recently presented psychogenic non-epileptic seizures (pseudoseizures). Real seizures resulted in a significant decrease of membrane serotonin transporter density. In the instances of pseudoseizures, its membrane density was undistinguishable from that of normal controls. These data lend further support to the idea that down regulation of serotonin transporter may play a homeostatic role in the cessation of epileptic seizures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427983     DOI: 10.1007/s11064-008-9708-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

2.  Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Authors:  S Z Langer; A M Galzin; M F Poirier; H Loo; D Sechter; E Zarifian
Journal:  J Recept Res       Date:  1987

3.  Diagnostic delay in psychogenic nonepileptic seizures.

Authors:  M Reuber; G Fernández; J Bauer; C Helmstaedter; C E Elger
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

4.  Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats.

Authors:  Y Wada; J Shiraishi; M Nakamura; H Hasegawa
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116).

Authors:  J D Leander
Journal:  Epilepsia       Date:  1992 May-Jun       Impact factor: 5.864

6.  Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.

Authors:  Q S Yan; P C Jobe; J W Dailey
Journal:  Eur J Pharmacol       Date:  1994-01-24       Impact factor: 4.432

7.  Anticonvulsant effect of intranigral fluoxetine.

Authors:  A Pasini; A Tortorella; K Gale
Journal:  Brain Res       Date:  1992-10-16       Impact factor: 3.252

8.  The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis.

Authors:  E Favale; D Audenino; L Cocito; C Albano
Journal:  Seizure       Date:  2003-07       Impact factor: 3.184

9.  Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

Authors:  S M Paul; M Rehavi; P Skolnick; J C Ballenger; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1981-12

Review 10.  High-affinity 3H-imipramine binding: a new biological marker in depression.

Authors:  S Z Langer; E Zarifian; M Briley; R Raisman; D Sechter
Journal:  Pharmacopsychiatria       Date:  1982-01
View more
  3 in total

Review 1.  Some cross-talks between immune cells and epilepsy should not be forgotten.

Authors:  Hong Wang; Sibo Liu; Zeyao Tang; Jinjie Liu
Journal:  Neurol Sci       Date:  2014-09-25       Impact factor: 3.307

2.  Serum serotonin levels in patients with epileptic seizures.

Authors:  Arun Murugesan; M R Sandhya Rani; Johnson Hampson; Bilal Zonjy; Nuria Lacuey; Carl L Faingold; Daniel Friedman; Orrin Devinsky; Rup K Sainju; Stephan Schuele; Beate Diehl; Maromi Nei; Ronald M Harper; Lisa M Bateman; George Richerson; Samden D Lhatoo
Journal:  Epilepsia       Date:  2018-05-17       Impact factor: 5.864

3.  N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism.

Authors:  Keiko Iwata; Hideo Matsuzaki; Taro Tachibana; Koji Ohno; Saori Yoshimura; Hironori Takamura; Kohei Yamada; Shinsuke Matsuzaki; Kazuhiko Nakamura; Kenji J Tsuchiya; Kaori Matsumoto; Masatsugu Tsujii; Toshirou Sugiyama; Taiichi Katayama; Norio Mori
Journal:  Mol Autism       Date:  2014-05-10       Impact factor: 7.509

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.